Karen Jean Ferrante
Director · Cogent Biosciences, Inc.
Individual
- 2024
- Oct 5, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Karen Jean Ferrante files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $370.02M in COGT purchases and sales in the last 12 months
- John Edward Robinson - $3.49M in COGT purchases and sales in the last 12 months
- Jessica Sachs - $3.20M in COGT purchases and sales in the last 12 months
- John L. Green - $2.98M in COGT purchases and sales in the last 12 months
- Evan Kearns - $2.52M in COGT purchases and sales in the last 12 months
- Arlene Morris - $1.69M in COGT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Karen Jean Ferrante?
Karen Jean Ferrante is a corporate insider, tracked as Director of Cogent Biosciences, Inc. (COGT). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Karen Jean Ferrante submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
